# EXSULIN Corp: Form D filings

EXSULIN Corp, a biotechnology company in Burnsville, MN, filed 5 Form D notices with the SEC between 2009 and 2013. The latest, on August 8, 2013, reports $153,750 sold of a $4 million offering to 4 investors.

Find out what EXSULIN Corp does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20EXSULIN%20Corp%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=EXSULIN%20Corp&page=%2Fdata%2Fform-d%2Fcompany%2Fexsulin-corp-1456348)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20EXSULIN%20Corp%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=EXSULIN%20Corp&page=%2Fdata%2Fform-d%2Fcompany%2Fexsulin-corp-1456348)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Minnesota](https://specstream.ai/data/form-d/state/minnesota): 692 rows, by operating companies, filed since November 1, 2024, $34.60, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/minnesota
- [Form D filings in Biotechnology](https://specstream.ai/data/form-d/industry/biotechnology): 1,568 rows, by operating companies, filed since November 1, 2024, $78.40, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/biotechnology

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 2809 VALLEY VIEW ROAD, Burnsville, MN, 55306
- Phone: (952) 898-5814
- Industry: Biotechnology
- Entity type: Corporation
- Incorporated in: Delaware
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506
- SEC identifier (CIK): 1456348

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Aug 8, 2013 | New notice | $4,000,000 | $153,750 | $3,846,250 | 4 | Jul 29, 2013 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1456348/000136211813000091/0001362118-13-000091-index.htm) |
| May 30, 2012 | New notice | $4,000,000 | $350,000 | $3,650,000 | 1 | May 21, 2012 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1456348/000136211812000072/0001362118-12-000072-index.htm) |
| Aug 23, 2010 | New notice | $1,000,000 | $100,000 | $900,000 | 1 | Aug 15, 2010 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1456348/000145634810000002/0001456348-10-000002-index.htm) |
| Apr 15, 2010 | New notice | $1,500,000 | $120,000 | $1,380,000 | 1 | Apr 9, 2010 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1456348/000145634810000001/0001456348-10-000001-index.htm) |
| Nov 20, 2009 | New notice | $300,000 | $300,000 | $0 | 1 | Oct 1, 2009 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1456348/000145634809000002/0001456348-09-000002-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Alexander Fleming | Executive Officer, Director, Promoter |  |
| Scott Jones | Executive Officer, Director |  |
| Lisa Jansa | Executive Officer, Director, Promoter |  |

## Other biotechnology companies in Minnesota that filed recently

- [Medical 21, Inc.](https://specstream.ai/data/form-d/company/medical-21-inc-1673688) $550,000 · Oct 23, 2026
- [InSitu Biologics, Inc.](https://specstream.ai/data/form-d/company/insitu-biologics-inc-1723443) $1.3 million · Oct 14, 2026
- [Evia Bio, Inc.](https://specstream.ai/data/form-d/company/evia-bio-inc-1954759) $5.5 million · Sep 28, 2026
- [EyeMacular Regeneration, Inc.](https://specstream.ai/data/form-d/company/eyemacular-regeneration-inc-2042485) $2.9 million · Sep 25, 2026
- [ProEncia Biotechnology Inc.](https://specstream.ai/data/form-d/company/proencia-biotechnology-inc-2103044) $1.5 million · Aug 26, 2026

[Every Form D from the week of Aug 5, 2013](https://specstream.ai/data/form-d/week/2013-08-05) · [All recent filings in Minnesota](https://specstream.ai/data/form-d/state/minnesota) · [All recent Biotechnology filings](https://specstream.ai/data/form-d/industry/biotechnology)

Read from SEC EDGAR. Amount sold is what EXSULIN Corp reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).